LLY · 10-Q · 2026Q1 · Full report

Liquidity and Cash Position

ELI LILLY & Co · 2026-04-30 · Importance 59 · Surprise 48 · From source text

Cash and cash equivalents decreased to $5.3 billion as of March 31, 2026 from $7.3 billion as of December 31, 2025. Lilly held total investments of $3.3 billion as of March 31, 2026 and had approximately $850 million of unfunded commitments to invest in venture capital funds, payable over up to 10 years. The company also reported $10.1 billion of unused committed bank credit facilities (with $10.0 billion available to support the commercial paper program) to support short-term funding. Management believes available cash, operating cash flow, and borrowing access are sufficient to fund existing and planned capital requirements, but notes near-term capex has increased for manufacturing expansion.

Key facts

• Cash and cash equivalents decreased to $5.3 billion as of March 31, 2026, compared with $7.3 billion as of December 31, 2025. source
• As of March 31, 2026, we had approximately $850 million of unfunded commitments to invest in venture capital funds, which we anticipate will be paid over a period of up to 10 years. source
• Total investments were $3.3 billion as of March 31, 2026 and $2.9 billion as of December 31, 2025. source
• We believe our available cash and cash equivalents, together with our ability to generate operating cash flow and our access to short-term and long-term borrowings, are sufficient to fund our existing and planned capital requirements. source

Impact estimates